{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:07Z","timestamp":1787010187425,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome that may confer increased pancreatic cancer (PC) risk. This study assesses PC risk and the rate of pancreatic imaging abnormalities in LFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      PC prevalence in LFS was calculated for individuals with a known\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      variant from the IARC\/NCI database. Pancreatic imaging studies across 3 institutional LFS cohorts were reviewed and compared using the Fisher exact test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 3043 individuals with LFS in the IARC\/NCI database, 46 (1.5%) had PC, and 42\/1243 (3.4%) LFS families had a member with PC. Among PCs with a known age of diagnosis, 2.6% and 43.2% were diagnosed before age 30 and 50, respectively. Across 3 institutional LFS cohorts, 32\/329 (9.7%) individuals had a pancreatic imaging abnormality, including cysts in 20 (6.1%) and a mass in 4 (1.2%). Whole-body MRI (WBMRI) had the lowest detection rate of pancreatic abnormalities (6%), whereas endoscopic ultrasound (EUS)\/MRI abdomen (MRI Abd) had the highest (50% and \ufeff20.8%, respectively). Cysts were detected more frequently with EUS\/MRI Abd (33.1% and \ufeff18.1%, respectively) compared with WBMRI (4.3%). Individuals older than age 50 were more likely to have a pancreatic abnormality (35.8% vs. 4.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01) or pancreatic cyst (26.4% vs. 2.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) compared with those younger than age 50.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PC may occur earlier in LFS compared with the general population. WBMRI identifies pancreatic abnormalities less frequently than other pancreatic cancer screening modalities in LFS. If dedicated PC screening is performed in LFS, screening should likely start before age 50 and use either EUS or MRI Abd.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002483","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T11:02:12Z","timestamp":1740567732000},"page":"e618-e623","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pancreatic Cancer Risk and Screening Outcomes in Li-Fraumeni Syndrome"],"prefix":"10.1097","volume":"54","author":[{"given":"Conrad J.","family":"Fernandes","sequence":"first","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun K.","family":"Du","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Naumer","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Kagami","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Le","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Good","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melani","family":"Duvall","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn","family":"Powers","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Zelley","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D.\ufeff","family":"Maese","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"MacFarland","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Kohlmann","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara N.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryson W.","family":"Katona","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8]]},"reference":[{"key":"R1-20250711","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"R2-20250711","first-page":"1932","article-title":"P53 germline mutations in childhood cancers and cancer risk for carrier individuals","volume":"82","author":"Chompret","year":"2000","journal-title":"Br J Cancer"},{"key":"R3-20250711","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"R4-20250711","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer screening recommendations for individuals with Li-Fraumeni syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"R5-20250711","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"key":"R6-20250711","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.gastro.2005.10.014","article-title":"Prevalence of early onset colorectal cancer in 397 patients with classic Li\u2013Fraumeni syndrome","volume":"130","author":"Wong","year":"2006","journal-title":"Gastroenterology"},{"key":"R7-20250711","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.gastro.2018.09.036","article-title":"Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni syndrome","volume":"156","author":"MacFarland","year":"2019","journal-title":"Gastroenterology"},{"key":"R8-20250711","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.14309\/ajg.0000000000000935","article-title":"Upper gastrointestinal cancer risk and surveillance outcomes in Li-Fraumeni syndrome","volume":"115","author":"Katona","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R9-20250711","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":"TP53 germline mutation testing in 180 families suspected of Li\u2013Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes","volume":"47","author":"Ruijs","year":"2010","journal-title":"J Med Genet"},{"key":"R10-20250711","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","article-title":"Relative frequency and morphology of cancers in carriers of germline TP53 mutations","volume":"20","author":"Birch","year":"2001","journal-title":"Oncogene"},{"key":"R11-20250711","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype\u2013phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"de Andrade","year":"2021","journal-title":"Lancet Oncol"},{"key":"R12-20250711","doi-asserted-by":"crossref","first-page":"e2300453","DOI":"10.1200\/PO.23.00453","article-title":"Cancer risks associated with TP53 pathogenic variants: maximum likelihood analysis of extended pedigrees for diagnosis of first cancers beyond the Li-Fraumeni syndrome spectrum","volume":"8","author":"Fortuno","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"R13-20250711","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Electronic address: andrew_aguirre@dfci.harvard.edu, Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"key":"R14-20250711","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41418-022-00976-3","article-title":"The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute","volume":"29","author":"de Andrade","year":"2022","journal-title":"Cell Death Differ"},{"key":"R16-20250711","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/ajg.2010.122","article-title":"Prevalence of incidental pancreatic cysts in the adult population on MR imaging","volume":"105","author":"Lee","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R17-20250711","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.gastro.2021.10.014","article-title":"Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals","volume":"162","author":"Overbeek","year":"2022","journal-title":"Gastroenterology"},{"key":"R18-20250711","first-page":"90","article-title":"Prevalence of incidental pancreatic cyst on upper endoscopic ultrasound","volume":"31","author":"Mart\u00ednez","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"R19-20250711","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/MPA.0000000000001918","article-title":"Prevalence, incidence, and risk of progression of asymptomatic pancreatic cysts in large sample real-world data","volume":"50","author":"Schweber","year":"2021","journal-title":"Pancreas"},{"key":"R20-20250711","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00535-016-1196-y","article-title":"Pancreatic cysts in general population on ultrasonography: prevalence and development of risk score","volume":"51","author":"Soroida","year":"2016","journal-title":"J Gastroenterol"},{"key":"R21-20250711","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0016-5107(04)02758-0","article-title":"Age-related changes in the pancreas identified by EUS: a prospective evaluation","volume":"61","author":"Rajan","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"R22-20250711","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.22.00298","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival","volume":"40","author":"Dbouk","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T20:00:12Z","timestamp":1752264012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002483","relation":{},"ISSN":["1536-4828"],"issn-type":[{"value":"1536-4828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"2024-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}